Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state
Trevelin, S. C., dos Santos, C. X., Ferreira, R. G. , de Sá Lima, L., Silva, R. L., Scavone, C., Curi, R., Alves-Filho, J. C., Cunha, T. M., Roxo-Júnior, P., Cervi, M-C., Laurindo, F. R. M., Hothersall, J. S., Cobb, A. M. ORCID: 0000-0003-2163-5999, Zhang, M., Ivetic, A., Shah, A. M., Lopes, L. R. & Cunha, F. Q. (2016). Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state. Scientific Reports, 6(1), article number 34581. doi: 10.1038/srep34581
Abstract
The reactive-oxygen-species-(ROS)-generating-enzyme Nox2 is essential for leukocyte anti-microbial activity. However its role in cellular redox homeostasis and, consequently, in modulating intracellular signaling pathways remains unclear. Herein, we show Nox2 activation favors thioredoxin-1 (TRX-1)/p40phox interaction, which leads to exclusion of TRX-1 from the nucleus. In contrast, the genetic deficiency of Nox2 or its pharmacological inhibition with apocynin (APO) results in reductive stress after lipopolysaccharide-(LPS)-cell stimulation, which causes nuclear accumulation of TRX-1 and enhanced transcription of inflammatory mediators through nuclear-factor-(NF)-κB. The NF-κB overactivation is prevented by TRX-1 oxidation using inhibitors of thioredoxin reductase-1 (TrxR-1). The Nox2/TRX-1/NF-κB intracellular signaling pathway is involved in the pathophysiology of chronic granulomatous disease (CGD) and sepsis. In fact, TrxR-1 inhibition prevents nuclear accumulation of TRX-1 and LPS-stimulated hyperproduction of tumor-necrosis-factor-(TNF)-α by monocytes and neutrophils purified from blood of CGD patients, who have deficient Nox2 activity. TrxR-1 inhibitors, either lanthanum chloride (LaCl3) or auranofin (AUR), also increase survival rates of mice undergoing cecal-ligation-and-puncture-(CLP). Therefore, our results identify a hitherto unrecognized Nox2-mediated intracellular signaling pathway that contributes to hyperinflammation in CGD and in septic patients. Additionally, we suggest that TrxR-1 inhibitors could be potential drugs to treat patients with sepsis, particularly in those with CGD.
Publication Type: | Article |
---|---|
Additional Information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
Publisher Keywords: | Mechanisms of disease, Molecular medicine, NF-kappaB, Sepsis, Stress signalling |
Subjects: | Q Science > QH Natural history > QH301 Biology R Medicine > R Medicine (General) |
Departments: | School of Health & Psychological Sciences |
SWORD Depositor: |
Available under License Creative Commons: Attribution International Public License 4.0.
Download (1MB) | Preview
Export
Downloads
Downloads per month over past year